Atlas Trials

Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan

Clinical trial NCT04991207 · COMPLETED

Trial details

NCT number
NCT04991207
Sponsor
Bial - Portela C S.A.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pulmonary Arterial Hypertension
Start date
2018-02-06
Primary completion
2018-05-14
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.